5th Drug Discovery Innovation programme 24-25 May 2018 Embassy Suites by Hilton Boston at Logan Airport Boston, US. This is a two days event, our professionals will be talking on new compounds, target validation and novel drug design methods and technologies.
- Target engagement
- Advances in medicinal chemistry
- Pre-clinical pharmacokinetics
- Modern approaches for drug design
- Role of AI in drug discovery
- Open innovation
- Computational approaches
- Molecular dynamics
- Biologics as potential therapeutics
Dr. Paul Helbling from Dualsystems Biotech AG is talking about “LRC-TriCEPS target identification on living cells”, so you can learn more about the new LRC-TriCEPS (Ligand-receptor capture) technology to identify targets and off-targets of your ligands on the living cells.
If you would like to meet Paul you can reach him via email firstname.lastname@example.org or mobile +41 76 422 55 05